Randomized Multicenter Study on the Efficacy and Safety of Favipiravir for Parenteral Administration Compared to Standard of Care in Hospitalized Patients With COVID-19

NCT05185284 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

217

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Favipiravir
DRUG: Favipiravir
DRUG: Remdesivir

Sponsor

Promomed, LLC

Collaborators

[object Object]